reolysin: Clinical Trials

1 trial of reolysin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow reolysin: new trials by email Literature Review of reolysin trials Research Report on reolysin

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
REOLYSIN, Carboplatin, Paclitaxel - Carcinoma, Squamous Cell of the Head and Neck
Phase 3CompletedOncolytics Biotech1672010-06-012014-11-05

Conditions studied

Carcinoma (1)  ·  Neoplasm Metastasis (1)  ·  Recurrence (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Oncolytics Biotech (1)

Countries

Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)  ·  Italy (1)  ·  Poland (1)  ·  Russia (1)  ·  Slovenia (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

James A Bonner, MD (1)  ·  Jan Vermorken, MD, PhD (1)  ·  Kevin Harrington, MBBS MRCP FRCR (1)